Molecular Neurodegeneration
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 19.6 | Q1 | 98.8% | 6.262 | Q1 | 99.4% |
| 2024 | 17.5 | Q1 | 99.0% | 5.488 | Q1 | 99.2% |
| 2023 | 14.9 | Q1 | 98.5% | 5.205 | Q1 | 99.1% |
| 2022 | 15.1 | Q1 | 97.5% | 5.158 | Q1 | 99.2% |
| 2021 | 18.9 | Q1 | 99.0% | 4.731 | Q1 | 99.0% |
| 2020 | — | — | 5.565 | Q1 | 99.2% | |
| 2019 | — | — | 4.040 | Q1 | 98.8% | |
| 2018 | — | — | 3.988 | Q1 | 98.5% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
ISSN
1750-1326
country
GBcoverage
2006-2026